[O5] Oral Presentations 5

11:24 AM - 11:31 AM JST(2:24 AM - 2:31 AM UTC)

[O5-03] Development of stromal cell–targeted therapies to prevent COVID-19 progression to severe disease

*Taku Kureha¹, Hiroshi Takayanagi¹ (1. Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo (Japan))

Keywords:

Stromal immunology,Lymph node remodeling,Fibroblastic reticular cell,mRNA-LNP vaccine,ARDS

Password required to view

Log in

or